Europe must pay more for medicines, says Bayer

All NewsApril 1, 2026

German group’s pharma business expected to generate most of its revenues from US after strategic shift

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent